BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36537980)

  • 1. Muscle Channelopathies.
    Trivedi JR
    Continuum (Minneap Minn); 2022 Dec; 28(6):1778-1799. PubMed ID: 36537980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal Muscle Channelopathies.
    Vivekanandam V; Munot P; Hanna MG; Matthews E
    Neurol Clin; 2020 Aug; 38(3):481-491. PubMed ID: 32703462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics in skeletal muscle channelopathies.
    Vicino A; Brugnoni R; Maggi L
    Expert Rev Mol Diagn; 2023; 23(12):1175-1193. PubMed ID: 38009256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.
    Platt D; Griggs R
    Curr Opin Neurol; 2009 Oct; 22(5):524-31. PubMed ID: 19571750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle channelopathies.
    Saperstein DS
    Semin Neurol; 2008 Apr; 28(2):260-9. PubMed ID: 18351527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What the internist should know about hereditary muscle channelopathies.
    Bissay V; Van Malderen SCH
    Acta Clin Belg; 2018 Feb; 73(1):1-6. PubMed ID: 29088983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.
    Statland JM; Barohn RJ
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1598-614. PubMed ID: 24305449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nondystrophic myotonias.
    Heatwole CR; Moxley RT
    Neurotherapeutics; 2007 Apr; 4(2):238-51. PubMed ID: 17395134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and treatment of myotonic disorders.
    Heatwole CR; Statland JM; Logigian EL
    Muscle Nerve; 2013 May; 47(5):632-48. PubMed ID: 23536309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.
    Sun J; Luo S; Suetterlin KJ; Song J; Huang J; Zhu W; Xi J; Zhou L; Lu J; Lu J; Zhao C; Hanna MG; Männikkö R; Matthews E; Qiao K
    Neuromuscul Disord; 2021 Sep; 31(9):829-838. PubMed ID: 33965302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle channelopathies and related diseases.
    Fontaine B
    Handb Clin Neurol; 2013; 113():1433-6. PubMed ID: 23622365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle channelopathies: a guide to diagnosis and management.
    Matthews E; Holmes S; Fialho D
    Pract Neurol; 2021 Jun; 21(3):196-204. PubMed ID: 33563766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
    Corrochano S; Männikkö R; Joyce PI; McGoldrick P; Wettstein J; Lassi G; Raja Rayan DL; Blanco G; Quinn C; Liavas A; Lionikas A; Amior N; Dick J; Healy EG; Stewart M; Carter S; Hutchinson M; Bentley L; Fratta P; Cortese A; Cox R; Brown SD; Tucci V; Wackerhage H; Amato AA; Greensmith L; Koltzenburg M; Hanna MG; Acevedo-Arozena A
    Brain; 2014 Dec; 137(Pt 12):3171-85. PubMed ID: 25348630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing in skeletal muscle ion channelopathies.
    Altamura C; Saltarella I; Campanale C; Laghetti P; Desaphy JF
    Curr Opin Pharmacol; 2023 Feb; 68():102329. PubMed ID: 36512979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle channelopathies.
    Vivekanandam V; Jayaseelan D; Hanna MG
    Handb Clin Neurol; 2023; 195():521-532. PubMed ID: 37562884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
    Raja Rayan DL; Hanna MG
    Curr Opin Neurol; 2010 Oct; 23(5):466-76. PubMed ID: 20634695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.